Ibrahim Shatat to Cohort Studies
This is a "connection" page, showing publications Ibrahim Shatat has written about Cohort Studies.
Connection Strength
0.180
-
The efficacy and safety of intravenous hydralazine for the treatment of hypertension in the hospitalized child. Pediatr Nephrol. 2014 Aug; 29(8):1403-9.
Score: 0.074
-
Blood pressure reclassification in adolescents based on repeat clinic blood pressure measurements. J Clin Hypertens (Greenwich). 2013 Oct; 15(10):717-22.
Score: 0.071
-
The impact of disease duration on quality of life in children with nephrotic syndrome: a Midwest Pediatric Nephrology Consortium study. Pediatr Nephrol. 2015 Sep; 30(9):1467-76.
Score: 0.020
-
A critical analysis of racial difference with mycophenolate mofetil (MMF) dosing, clinical outcomes and adverse effects in pediatric kidney transplant patients. Clin Transplant. 2011 Jul-Aug; 25(4):534-40.
Score: 0.014